CN107259517A - A kind of ferfas can containing hawthorn and its preparation method and application - Google Patents
A kind of ferfas can containing hawthorn and its preparation method and application Download PDFInfo
- Publication number
- CN107259517A CN107259517A CN201710548981.7A CN201710548981A CN107259517A CN 107259517 A CN107259517 A CN 107259517A CN 201710548981 A CN201710548981 A CN 201710548981A CN 107259517 A CN107259517 A CN 107259517A
- Authority
- CN
- China
- Prior art keywords
- ferfas
- hawthorn
- draining
- weight
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000009917 Crataegus X brevipes Nutrition 0.000 title claims abstract description 45
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 title claims abstract description 45
- 235000009685 Crataegus X maligna Nutrition 0.000 title claims abstract description 45
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 title claims abstract description 45
- 235000009486 Crataegus bullatus Nutrition 0.000 title claims abstract description 45
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 title claims abstract description 45
- 235000009682 Crataegus limnophila Nutrition 0.000 title claims abstract description 45
- 235000004423 Crataegus monogyna Nutrition 0.000 title claims abstract description 45
- 235000002313 Crataegus paludosa Nutrition 0.000 title claims abstract description 45
- 235000009840 Crataegus x incaedua Nutrition 0.000 title claims abstract description 45
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 240000000171 Crataegus monogyna Species 0.000 title 1
- 241001092040 Crataegus Species 0.000 claims abstract description 44
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims abstract description 36
- 239000000463 material Substances 0.000 claims abstract description 29
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 18
- 206010033546 Pallor Diseases 0.000 claims abstract description 16
- 150000003839 salts Chemical class 0.000 claims abstract description 12
- 235000021552 granulated sugar Nutrition 0.000 claims abstract description 11
- 208000020832 chronic kidney disease Diseases 0.000 claims abstract description 9
- 241000607479 Yersinia pestis Species 0.000 claims abstract description 8
- 201000010099 disease Diseases 0.000 claims abstract description 8
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims abstract description 8
- 208000022831 chronic renal failure syndrome Diseases 0.000 claims abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 4
- 230000001954 sterilising effect Effects 0.000 claims description 10
- 238000004659 sterilization and disinfection Methods 0.000 claims description 10
- 235000013599 spices Nutrition 0.000 claims description 8
- 238000004140 cleaning Methods 0.000 claims description 7
- 230000002950 deficient Effects 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 7
- 239000002994 raw material Substances 0.000 claims description 7
- 238000007789 sealing Methods 0.000 claims description 7
- 238000000034 method Methods 0.000 claims description 5
- 241000894006 Bacteria Species 0.000 claims description 3
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 abstract description 10
- 210000002700 urine Anatomy 0.000 abstract description 10
- 102000004169 proteins and genes Human genes 0.000 abstract description 7
- 108090000623 proteins and genes Proteins 0.000 abstract description 7
- 210000003743 erythrocyte Anatomy 0.000 abstract description 6
- PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 abstract description 5
- 229940109239 creatinine Drugs 0.000 abstract description 5
- 102000001554 Hemoglobins Human genes 0.000 abstract description 4
- 108010054147 Hemoglobins Proteins 0.000 abstract description 4
- 208000001647 Renal Insufficiency Diseases 0.000 abstract description 4
- 201000006370 kidney failure Diseases 0.000 abstract description 4
- 208000004880 Polyuria Diseases 0.000 abstract description 3
- 230000035619 diuresis Effects 0.000 abstract description 3
- 230000009467 reduction Effects 0.000 abstract description 3
- 239000003205 fragrance Substances 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 241000700159 Rattus Species 0.000 description 10
- 230000000694 effects Effects 0.000 description 9
- 210000003734 kidney Anatomy 0.000 description 8
- 241001465754 Metazoa Species 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 241000609666 Tuber aestivum Species 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 239000009320 niaoduqing keli Substances 0.000 description 3
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 210000000683 abdominal cavity Anatomy 0.000 description 2
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 2
- 238000011047 acute toxicity test Methods 0.000 description 2
- 239000000654 additive Substances 0.000 description 2
- 230000000996 additive effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 208000015181 infectious disease Diseases 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- QGXBDMJGAMFCBF-HLUDHZFRSA-N 5α-Androsterone Chemical compound C1[C@H](O)CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CC[C@H]21 QGXBDMJGAMFCBF-HLUDHZFRSA-N 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- QGXBDMJGAMFCBF-UHFFFAOYSA-N Etiocholanolone Natural products C1C(O)CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC21 QGXBDMJGAMFCBF-UHFFFAOYSA-N 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000223977 Tuber melanosporum Species 0.000 description 1
- 235000002777 Tuber melanosporum Nutrition 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 229940061641 androsterone Drugs 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 235000020774 essential nutrients Nutrition 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 238000003304 gavage Methods 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000013059 nephrectomy Methods 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 238000007493 shaping process Methods 0.000 description 1
- 150000003408 sphingolipids Chemical class 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 238000012549 training Methods 0.000 description 1
- 238000002054 transplantation Methods 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 239000000052 vinegar Substances 0.000 description 1
- 235000021419 vinegar Nutrition 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L31/00—Edible extracts or preparations of fungi; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/01—Instant products; Powders; Flakes; Granules
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L19/00—Products from fruits or vegetables; Preparation or treatment thereof
- A23L19/03—Products from fruits or vegetables; Preparation or treatment thereof consisting of whole pieces or fragments without mashing the original pieces
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
- A61K36/734—Crataegus (hawthorn)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
The invention discloses a kind of ferfas can containing hawthorn and its preparation method and application, no disease and pests harm is selected, non-rot ferfas and hawthorn；The steps such as sliced, rinsing, blanching, draining；Dispensing is weighed, after the water dissolving for adding dispensing gross weight 3%, then is uniformly admixed in the material after draining；Load container, sterilize, examine and qualified produce ferfas can；The dispensing based on the weight of material after draining including：Edible salt 0.8 1.5%, white granulated sugar 0.9 1.3%, citric acid 0.01 0.03%.The present invention does not only have the original mouthfeel of ferfas, and adds the sour-sweet and delicate fragrance of hawthorn, harmless, edible safety.The present invention has reduction urea nitrogen, creatinine to act on to chronic renal failure symptom, can increase red blood cell, content of hemoglobin, reduces Urine proteins, has diuresis, a kind of new medicine is provided for kidney failure.
Description
Technical field
The present invention relates to edible mushroom field of deep, specifically a kind of ferfas can containing hawthorn and preparation method thereof and
Using.
Background technology
Ferfas is a class hypogeal fungus, and main edible kind is three kinds of black truffle, summer truffle and white ferfas.Its semi-artificial cultivation
The method of training is close：Breeding program is to grow saplings；Artificial infection forms infection seedling；Infect transplantation of seedlings；Turn over the management such as root finishing；
5-7 initially forms fructification.The sustainable shaping 20-30 of fructification.Ferfas has a variety of curative effects, rich in 17 kinds of amino acid, 8 kinds
Vitamin, appropriate protein and androsterone, sterol, sphingolipid, aliphatic acid, amino acid and trace element etc. more than 50 plants physiology
Active component.And the essential nutrients such as 8 kinds of amino acid, zinc, manganese, iron, calcium, phosphorus, the selenium that can not be synthesized containing human body itself, tool
There are the medical values such as strengthen immunity, anti-aging, beneficial stomach, clear god, hemostasis, treatment hemorrhoid, with active anticancer, have necessarily to cancer cell
Inhibitory action, brain cell activity can be excited.There are the converted products such as Truffle wine, truffle oil, ferfas vinegar in current China, but in block
In terms of the exploitation of bacterium can, also in initial stage, and existing can, fried process is also have passed through mostly, have impact on ferfas only
Special local flavor.Also there is the problem of shelf-life is short, taste is single, additive usage amount is big has certain influence to health, battalion
Support value reduction.
The content of the invention
It is an object of the invention to provide a kind of ferfas can containing hawthorn and its preparation method and application, with solution
State the problem of being proposed in background technology.
To achieve the above object, the present invention provides following technical scheme：
A kind of preparation method of the ferfas can containing hawthorn, comprises the following steps：
(1) raw material selection：No disease and pests harm, non-rot ferfas and hawthorn；
(2) cut into slices：Ferfas and hawthorn are cut into slices, the thickness of piece is 3-5mm；
(3) rinse：Cleaning 2-3 times, cleans impurity；
(4) blanching, draining：100 DEG C are heated water to, then by the section blanching 1-1.5min after above-mentioned rinsing, is taken out
After weigh, the 40-45% of draining to the weight；
(5) spice：Weigh dispensing, the dispensing based on the weight of material after draining including：Edible salt 0.8-1.5%, white sand
Sugared 0.9-1.3%, citric acid 0.01-0.03%, after the water dissolving for adding dispensing gross weight 3%, then are uniformly admixed after draining
In material；
(6) container, sterilization are loaded：The above-mentioned material mixed is fitted into clean container, in 105-110 DEG C of temperature after sealing
The lower sterilization 1-1.5min of degree, is rapidly cooled to 3-6 DEG C, then tests, and rejects defective work, produces ferfas can.
It is used as further scheme of the invention：In step (2), the mass ratio of ferfas and hawthorn is 2-6:1-3.
It is used as further scheme of the invention：In step (2), the mass ratio of ferfas and hawthorn is 3-5:2.
It is used as further scheme of the invention：In step (4), the 42% of draining to the weight.
It is used as further scheme of the invention：In step (5), dispensing based on the weight of material after draining including：Edible salt
1-1.3%, white granulated sugar 1-1.2%, citric acid 0.02%.
It is used as further scheme of the invention：In step (5), dispensing based on the weight of material after draining including：Edible salt
1.2%th, white granulated sugar 1.1%, citric acid 0.02%.
Another object of the present invention is to provide ferfas can made from methods described.
Another object of the present invention is to provide application of the ferfas can in treatment chronic renal failure medicine is prepared.
Compared with prior art, the beneficial effects of the invention are as follows：
The invention provides a kind of new ferfas can, ferfas and hawthorn cooperation are handled, do not have local flavor, it is nutritious,
Do not only have the original mouthfeel of ferfas, and add the sour-sweet and delicate fragrance of hawthorn, walked by blanching, draining, spice, high temperature sterilization etc.
Suddenly, it substantially prolongs the shelf-life of ferfas can.Additive usage amount of the present invention is minimum, harmless, further promotes to protect
Deposit effect.In addition, being found through experiment, the present invention has reduction urea nitrogen, creatinine to act on to chronic renal failure symptom, can increase
Red blood cell, content of hemoglobin, reduce Urine proteins, have diuresis, single hawthorn or ferfas do not have the effect above.This
Invent and provide a kind of new medicine for kidney failure, tool has an unexpected effect.
Embodiment
Below in conjunction with the embodiment of the present invention, the technical scheme in the embodiment of the present invention is clearly and completely described,
Obviously, described embodiment is only a part of embodiment of the invention, rather than whole embodiments.Based in the present invention
Embodiment, the every other embodiment that those of ordinary skill in the art are obtained under the premise of creative work is not made, all
Belong to the scope of protection of the invention.
Embodiment 1
In the embodiment of the present invention, a kind of preparation method of the ferfas can containing hawthorn comprises the following steps：
(1) raw material selection：No disease and pests harm, non-rot ferfas and hawthorn.
(2) cut into slices：Ferfas and hawthorn are cut into slices, the thickness of piece is 3-5mm, and wherein the mass ratio of ferfas and hawthorn is 2:3.
(3) rinse：Cleaning 2-3 times, cleans impurity.
(4) blanching, draining：100 DEG C are heated water to, then by the section blanching 1min after above-mentioned rinsing, is claimed after taking-up
Weight, the 40% of draining to the weight.
(5) spice：Weigh dispensing, the dispensing based on the weight of material after draining including：Edible salt 0.8%, white granulated sugar
0.9%th, citric acid 0.01%, after the water dissolving for adding dispensing gross weight 3%, then is uniformly admixed in the material after draining.
(6) container, sterilization are loaded：The above-mentioned material mixed is fitted into clean container, after sealing at a temperature of 105 DEG C
1min is sterilized, 3 DEG C are rapidly cooled to, then tested, defective work is rejected, produces ferfas can.
Embodiment 2
In the embodiment of the present invention, a kind of preparation method of the ferfas can containing hawthorn comprises the following steps：
(1) raw material selection：No disease and pests harm, non-rot ferfas and hawthorn.
(2) cut into slices：Ferfas and hawthorn are cut into slices, the thickness of piece is 3-5mm, and wherein the mass ratio of ferfas and hawthorn is 6:1.
(3) rinse：Cleaning 2-3 times, cleans impurity.
(4) blanching, draining：100 DEG C are heated water to, then by the section blanching 1.5min after above-mentioned rinsing, after taking-up
Weigh, the 45% of draining to the weight.
(5) spice：Weigh dispensing, the dispensing based on the weight of material after draining including：Edible salt 1.5%, white granulated sugar
1.3%th, citric acid 0.03%, after the water dissolving for adding dispensing gross weight 3%, then is uniformly admixed in the material after draining.
(6) container, sterilization are loaded：The above-mentioned material mixed is fitted into clean container, after sealing at a temperature of 110 DEG C
1.5min is sterilized, 6 DEG C are rapidly cooled to, then tested, defective work is rejected, produces ferfas can.
Embodiment 3
In the embodiment of the present invention, a kind of preparation method of the ferfas can containing hawthorn comprises the following steps：
(1) raw material selection：No disease and pests harm, non-rot ferfas and hawthorn.
(2) cut into slices：Ferfas and hawthorn are cut into slices, the thickness of piece is 3-5mm, and wherein the mass ratio of ferfas and hawthorn is 3:2.
(3) rinse：Cleaning 2-3 times, cleans impurity.
(4) blanching, draining：100 DEG C are heated water to, then by the section blanching 1.1min after above-mentioned rinsing, after taking-up
Weigh, the 41% of draining to the weight.
(5) spice：Weigh dispensing, the dispensing based on the weight of material after draining including：Edible salt 1%, white granulated sugar 1%,
Citric acid 0.02%, after the water dissolving for adding dispensing gross weight 3%, then is uniformly admixed in the material after draining.
(6) container, sterilization are loaded：The above-mentioned material mixed is fitted into clean container, after sealing at a temperature of 106 DEG C
1.1min is sterilized, 4 DEG C are rapidly cooled to, then tested, defective work is rejected, produces ferfas can.
Embodiment 4
In the embodiment of the present invention, a kind of preparation method of the ferfas can containing hawthorn comprises the following steps：
(1) raw material selection：No disease and pests harm, non-rot ferfas and hawthorn.
(2) cut into slices：Ferfas and hawthorn are cut into slices, the thickness of piece is 3-5mm, and wherein the mass ratio of ferfas and hawthorn is 5:2.
(3) rinse：Cleaning 2-3 times, cleans impurity.
(4) blanching, draining：100 DEG C are heated water to, then by the section blanching 1.4min after above-mentioned rinsing, after taking-up
Weigh, the 44% of draining to the weight.
(5) spice：Weigh dispensing, the dispensing based on the weight of material after draining including：Edible salt 1.3%, white granulated sugar
1.2%th, citric acid 0.02%, after the water dissolving for adding dispensing gross weight 3%, then is uniformly admixed in the material after draining.
(6) container, sterilization are loaded：The above-mentioned material mixed is fitted into clean container, after sealing at a temperature of 108 DEG C
1.4min is sterilized, 5 DEG C are rapidly cooled to, then tested, defective work is rejected, produces ferfas can.
Embodiment 5
In the embodiment of the present invention, a kind of preparation method of the ferfas can containing hawthorn comprises the following steps：
(1) raw material selection：No disease and pests harm, non-rot ferfas and hawthorn.
(2) cut into slices：Ferfas and hawthorn are cut into slices, the thickness of piece is 3-5mm, and wherein the mass ratio of ferfas and hawthorn is 4:2.
(3) rinse：Cleaning 2-3 times, cleans impurity.
(4) blanching, draining：100 DEG C are heated water to, then by the section blanching 1.2min after above-mentioned rinsing, after taking-up
Weigh, the 42% of draining to the weight.
(5) spice：Weigh dispensing, the dispensing based on the weight of material after draining including：Edible salt 1.2%, white granulated sugar
1.1%th, citric acid 0.02%, after the water dissolving for adding dispensing gross weight 3%, then is uniformly admixed in the material after draining.
(6) container, sterilization are loaded：The above-mentioned material mixed is fitted into clean container, after sealing at a temperature of 107 DEG C
1.2min is sterilized, 5 DEG C are rapidly cooled to, then tested, defective work is rejected, produces ferfas can.
The present invention has found that it has certain curative effect to chronic renal failure in its effect experiment is carried out, and is described in detail below,
Tests below uses the ferfas can of embodiment 5.
Embodiment 6
The present invention is through animal acute toxicity test.Method is as follows：
1. the acute toxicity tests：20 small white mouses are taken, two groups are randomly divided into：A groups, B groups, every group 10.A is experiment
Group, B is control group.Component A not An adult human dose 1/10 amount ferfas can, adjust cold water gavage, normally feed continuous one week.
B groups take the physiological saline measured on an equal basis with A groups.Life is killed after stopping a day, makees every check.General signs, body to animal
Without substantially change, (physiological saline is compareed with B groups for the tissue of the main organs such as weight, outward appearance, behavior and conscience, spleen, lung, kidney, dirty
Group) no significant difference.
The present invention ferfas can shown in the zoopery of small white mouse Renal Failure Model its have drop serum creatinine,
Urea nitrogen, improves the effect of renal function.It is described in detail below.
2. the excision of pair Rat renal 5/6 causes the influence of renal failure：
Male rat 52 is taken, 3 groups are randomly divided into, Normal group 10, Sham-operated control group 10, and operation group 32
Only.That intraperitoneal injection of anesthesia of operation group rat 25mg/kg amobarbitals, belly unhairing, after sterilization, right kidney is extractd in midsection,
Simultaneously by the left nephrectomy 2/3, hemostasis rear enclosed abdominal cavity.Sham-operated control group is cut behind abdominal cavity, separates kidney peplos, and kidney is not cut off.
Postoperative 2 weekly selection survival rats (30) are only randomly divided into 3 groups.Sham-operated control group, Normal group, model control group are not administered,
Ferfas can group 4g/kg of the present invention, NIAODUQING KELI group 4.0g/kg distinguish gastric infusion, and successive administration 8 weeks terminates in experiment
Rat was placed in metabolic cage in first 2 days, water is can't help in fasting, collects 24h urines, determine urine volume, Urine proteins.1 is small after last dose
When rat is put to death, take blood and Virus monitory hematology and biochemical indicator, i.e. red blood cell (RBC), hemoglobin (Hb), urea
Nitrogen (BUN), creatinine (Cr) index, are shown in Table 1-3.
CRF rats BUN, Cr influence caused by the ferfas can of the present invention of table 1 is cut off to kidney 5/6
Note：Compared with sham-operation group, * P<0.05, * * P<0.01, compared with model control group, △ P<0.05.
The influence of CRF rat bloods change caused by the ferfas can of the present invention of table 2 is cut off to kidney 5/6
| Number of animals | Dosage (g/kg) | RBC(T/L) | Hb(g/L) | |
| Normal group | 10 | - | 7.35±1.08 | 146.8±6.28 |
| Sham-operated control group | 10 | - | 6.43±1.16 | 137.8±6.08 |
| Model control group | 10 | - | 4.63±1.89** | 102.9±7.16** |
| Of the present invention group | 10 | 4.0 | 6.51±1.18*△ | 132.0±5.26*△ |
| NIAODUQING KELI group | 10 | 4.0 | 6.03±1.52* | 128.3±4.58* |
Note：Compared with sham-operation group, * P<0.05, * * P<0.01, compared with model control group, △ P<0.05.
CRF rat 24h Urine proteins caused by the ferfas can of the present invention of table 3 is cut off on kidney 5/6, urine volume influence
| Number of animals | Dosage (g/kg) | Urine proteins (g/24h) | Urine volume (ml/24h) | |
| Model control group | 10 | - | 5.85±1.06 | 13.58±2.09 |
| Of the present invention group | 10 | 4.0 | 4.93±1.85** | 12.65±1.95* |
| NIAODUQING KELI group | 10 | 4.0 | 4.89±0.59** | 12.53±1.87* |
Note：Compared with model control group, * P<0.05, * * P<0.01.
As can be seen that Chronic Renal Failure Rats caused by ferfas can of the present invention is cut off to kidney 5/6 have drop from table 1-3
Low urea nitrogen, creatinine effect, can increase red blood cell, content of hemoglobin, reduce Urine proteins, there is diuresis.
It is obvious to a person skilled in the art that the invention is not restricted to the details of above-mentioned one exemplary embodiment, Er Qie
In the case of without departing substantially from spirit or essential attributes of the invention, the present invention can be realized in other specific forms.Therefore, no matter
From the point of view of which point, embodiment all should be regarded as exemplary, and be nonrestrictive, the scope of the present invention is by appended power
Profit is required rather than described above is limited, it is intended that all in the implication and scope of the equivalency of claim by falling
Change is included in the present invention.
Moreover, it will be appreciated that although the present specification is described in terms of embodiments, not each embodiment is only wrapped
Containing an independent technical scheme, this narrating mode of specification is only that for clarity, those skilled in the art should
Using specification as an entirety, the technical solutions in the various embodiments may also be suitably combined, forms those skilled in the art
It may be appreciated other embodiment.
Claims (8)
1. a kind of preparation method of the ferfas can containing hawthorn, it is characterised in that comprise the following steps：
（1）Raw material selection：No disease and pests harm, non-rot ferfas and hawthorn；
（2）Section：Ferfas and hawthorn are cut into slices, the thickness of piece is 3-5mm；
（3）Rinsing：Cleaning 2-3 times, cleans impurity；
（4）Blanching, draining：100 DEG C are heated water to, then by the section blanching 1-1.5min after above-mentioned rinsing, is claimed after taking-up
Weight, the 40-45% of draining to the weight；
（5）Spice：Weigh dispensing, the dispensing based on the weight of material after draining including：Edible salt 0.8-1.5%, white granulated sugar 0.9-
1.3%th, citric acid 0.01-0.03%, after the water dissolving for adding dispensing gross weight 3%, then is uniformly admixed in the material after draining；
（6）Load container, sterilization：The above-mentioned material mixed is fitted into clean container, after sealing at a temperature of 105-110 DEG C
1-1.5min is sterilized, 3-6 DEG C is rapidly cooled to, then tested, defective work is rejected, produces ferfas can.
2. the preparation method of the ferfas can according to claim 1 containing hawthorn, it is characterised in that step（2）In, block
The mass ratio of bacterium and hawthorn is 2-6:1-3.
3. the preparation method of the ferfas can according to claim 1 containing hawthorn, it is characterised in that step（2）In, block
The mass ratio of bacterium and hawthorn is 3-5:2.
4. the preparation method of the ferfas can according to claim 1 containing hawthorn, it is characterised in that step（4）In, drip
Water is to the 42% of the weight.
5. the preparation method of the ferfas can according to claim 1 containing hawthorn, it is characterised in that step（5）In, match somebody with somebody
Material based on the weight of material after draining including：Edible salt 1-1.3%, white granulated sugar 1-1.2%, citric acid 0.02%.
6. the preparation method of the ferfas can according to claim 1 containing hawthorn, it is characterised in that step（5）In, match somebody with somebody
Material based on the weight of material after draining including：Edible salt 1.2%, white granulated sugar 1.1%, citric acid 0.02%.
7. the ferfas can according to made from claim 1-6 any described methods.
8. application of the ferfas can according to claim 7 in treatment chronic renal failure medicine is prepared.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710548981.7A CN107259517A (en) | 2017-07-07 | 2017-07-07 | A kind of ferfas can containing hawthorn and its preparation method and application |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201710548981.7A CN107259517A (en) | 2017-07-07 | 2017-07-07 | A kind of ferfas can containing hawthorn and its preparation method and application |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN107259517A true CN107259517A (en) | 2017-10-20 |
Family
ID=60072240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201710548981.7A Pending CN107259517A (en) | 2017-07-07 | 2017-07-07 | A kind of ferfas can containing hawthorn and its preparation method and application |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN107259517A (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012078798A1 (en) * | 2010-12-07 | 2012-06-14 | Bananalogix, Inc. | Methods of processing organic matter and compositions thereof |
| CN102813181A (en) * | 2012-08-25 | 2012-12-12 | 丽江中源绿色食品有限公司 | Vinaigrette canned truffle and production method and device thereof |
| CN104172143A (en) * | 2014-08-25 | 2014-12-03 | 福建绿宝食品集团有限公司 | Making method of pleurotus eryngii can |
| CN106136014A (en) * | 2016-06-29 | 2016-11-23 | 江苏片山食品有限公司 | A kind of functional solid beverage and preparation method thereof |
-
2017
- 2017-07-07 CN CN201710548981.7A patent/CN107259517A/en active Pending
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012078798A1 (en) * | 2010-12-07 | 2012-06-14 | Bananalogix, Inc. | Methods of processing organic matter and compositions thereof |
| CN102813181A (en) * | 2012-08-25 | 2012-12-12 | 丽江中源绿色食品有限公司 | Vinaigrette canned truffle and production method and device thereof |
| CN104172143A (en) * | 2014-08-25 | 2014-12-03 | 福建绿宝食品集团有限公司 | Making method of pleurotus eryngii can |
| CN106136014A (en) * | 2016-06-29 | 2016-11-23 | 江苏片山食品有限公司 | A kind of functional solid beverage and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 熊永生编著: "《块菌栽培技术》", 31 December 2009, 云南科技出版社 * |
| 谢文英编著: "《吃对食物不生病-厨房里的大药房》", 31 March 2017, 安徽科学技术出版社 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7217763B2 (en) | Pharmaceutical and nutraceutical abscisic acid compositions | |
| CN107821713A (en) | Collagen mineral complex pressed candy | |
| Campbell-McBride | Gut and psychology syndrome | |
| CN102845361A (en) | Method for raising selenium-rich meiling sheep | |
| CN105211527A (en) | A kind of cultivation steamed crab feed and preparation method | |
| CN103783530B (en) | A kind of composite fishbone hormone chewable tablet | |
| CN107183400A (en) | A kind of egg feedstuff | |
| RU2478297C2 (en) | Syrniki preparation method | |
| JP2004065240A (en) | Seed and plant containing vitamin b12, and method for producing the same | |
| CN107259517A (en) | A kind of ferfas can containing hawthorn and its preparation method and application | |
| KR101642176B1 (en) | Composition for enhancing growth and reinforcing immunity | |
| KR20140056058A (en) | Feed additive for stock containing creosote | |
| CN105995576A (en) | Processing method of de-muttony treatment of mutton | |
| CN114467812B (en) | Tilapia embrittlement breeding method | |
| US20110294665A1 (en) | Bioactive agent, pharmaceutical product, cosmetic product, freshness keeping agent, and plant and animal growth promoting agent | |
| Yusuf et al. | Fura da nono drink and its implications in the treatment of malnutrition in Bauchi Metropolis of Bauchi State | |
| CN107802828A (en) | A kind of kallikrein parenteral solution | |
| CN103936518B (en) | A kind of plant health is fertile | |
| Emeruwa | Growth performance of west african dwarf sheep Fed diets supplemented with fossil shell flour | |
| KR102448416B1 (en) | A manufacturing method of health supplement for improving liver injury comprising Protaetia brevitarsis larvae and Vitamin C | |
| CN107494431A (en) | A kind of cultural method for improving black-bone chicken meat | |
| KR20120134308A (en) | Manufacturing method of functional kimchi containing enriched calcium of natural fermentation and the kimchi manufactured by this method | |
| Gosavi | Chapter-13 Buck Wheat: An Ideal Crop for Humans, Animals and Soil Health in Natural Farming | |
| CN115251250A (en) | High-density aquaculture liver-protecting feed additive and preparation method thereof | |
| DELİBORAN | AGRONOMIC BIOFORTIFICATION OF FOOD CROPS BY MICROELEMENTS FOR QUALITY NUTRITION |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination |